Τόμος 38 (2020) – Τεύχος 2 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 38 (2020) – Issue 2 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Από | | Πλήρες Κείμενο στα Ελληνικά - Full Text in Greek
Τίτλος – Title

Ροδόχρους νόσος: Θεραπεία ή πρόληψη; Ο ρόλος της Φωτοδυναμικής Θεραπείας

The Role of Photodynamic Therapy in Rosacea Acne
Συγγραφέας – Author

Φωτεινή Μπισκανάκη1,  Βασιλική Κεφαλά2

1Αισθητικός, Κοσμητολόγος, MSc, PhDc, Εργαστήριο Δερματολογίας -Αισθητικής- Εφαρμογών laser (lablad), Aκαδημαϊκός Υπότροφος, Τομέας Αισθητικής και Κοσμητολογίας, Τμήμα Βιοϊατρικών Επιστημών, Σχολή Επιστημών  Υγείας και Πρόνοιας, Πανεπιστήμιο Δυτικής Αττικής, Πανεπιστημιούπολη 1, Αγ. Σπυρίδωνος, Τ.Κ 12243, Αιγάλεω, Ελλάδα

2Αισθητικός, Κοσμητολόγος, Φαρμακοποιός Phd, Καθηγήτρια, Εργαστήριο Δερματολογίας-Αισθητικής- Εφαρμογών laser(lablad),Τομέας Αισθητικής και Κοσμητολογίας, Τμήμα Βιοϊατρικών Επιστημών, Σχολή Επιστημών  Υγείας και Πρόνοιας, Πανεπιστήμιο Δυτικής Αττικής, Πανεπιστημιούπολη 1, Αγ. Σπυρίδωνος, Τ.Κ 12243, Αιγάλεω, Ελλάδα

Foteini Biskanaki1, Vasiliki Kefala2 

1Aesthetician Cosmetologist, Pharmacist PhD, Professor, Laboratory of Dermatology-Aesthetics-laser applications (lablad), Sector of Aesthetics and Cosmetology, Department of Biomedical Sciences.Faculty of Health Sciences and Welfare. University of West Attica. Campus 1. Athens .Greece

2Aesthetician Cosmetologist MSc, PhDc, Academic Scholar, Laboratory of Dermatology-Aesthetics-laser applications (lablad), Sector of Aesthetics and Cosmetology, Department of Biomedical Sciences. Faculty  of Health Sciences and Welfare. University of West Attica. Campus 1. Athens. Greece
Παραπομπή – Citation

F. Biskanaki, V. Kefala. The Role of Photodynamic Therapy in Rosacea Acne. Epitheorese Klin. Farmakol. Farmakokinet. 2020, 38, 2, 109-117.
Ημερομηνία Δημοσιευσης – Publication Date
23-12-2019
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Ελληνικά – Greek
Λέξεις κλειδιά – Keywords

ροδόχρους ακμή, υπότυποι ροδόχρου ακμής, φωτοδυναμική θεραπεία, δερμοαισθητική θεραπεία, δερμοκαλλυντικά, φωτοευαισθητοποιητές, προσέγγιση ολιστικής υγειονομικής περίθαλψης

rosacea acne, rosacea subtypes, photodynamic therapy, dermoaesthetic care, dermocosmetic, photosensitizers, holistic health care approach
Λοιποί Όροι – Other Terms

Ανασκόπηση
Review Article
Περίληψη – Summary

Η ροδόχρους νόσος είναι μία χρόνια δερματική πάθηση που εκδηλώνεται με διαφορετικά συμπτώματα και ποικίλους βαθμούς σοβαρότητας. Κλινικά χαρακτηρίζεται ως ένα χρόνιο εξάνθημα που εντοπίζεται στo πρόσωπο. Προσβάλλει συχνότερα τις γυναίκες [1,2] και άτομα με ευαίσθητο δέρμα. Συνοδεύεται από περιόδους ύφεσης και έξαρσης. Σε αυτή την ανασκόπηση θα γίνει αναφορά στις ψυχοκοινωνικές επιπτώσεις της ροδόχρου νόσου, στη σπουδαιότητα της εκπαίδευσης των ασθενών, στη χρήση δερμοκαλλυντικών για την ενίσχυση της δράσης της συστηματικής θεραπείας, ενώ θα γίνει αναφορά στην Φωτοδυναμική θεραπεία PDT.

Rosacea is a long-term skin condition that manifests with different symptoms and varying degrees of severity. Clinically rosacea is characterized as a chronic rash, located on the facial area. The condition is common in people aged 30-60 originating in Southern Europe [1,2] and affects women to a greater extent. It occurs more frequently in people with sensitive skin and is accompanied by periods of recession and exacerbation. This review will focus on the psychosocial impacts of rosacea and on the importance of patient education, the use of dermatological cosmetics to enhance the effect of systemic therapy while referring to PDT.
Αναφορές – References
  1. Weinkle AP, Doktor V, Emer J. Update on the management of rosacea. 8:159-177. (2015)
  2. Fabbrocini G, Galliano MF, Aries MF, Vaissiere C, Duplan H, Coutanceau C, et al. Fragility of the epidermis, a common pathophysiological mechanism of acne vulgaris, rosacea and reactive skin involving inflammasome activation. InflammatCell Signaling.2(2):1-9. (2015)
  3. Kadunc B, Palermo E, Addor F, Metsavaht L, Rabello L, Mattos R, et al.Tratado de cirurgiadermatologica, cosmiatria e laser da sociedadeBrasileira de dermatologia. 2nd ed. Rio de Janeiro: Elsevier Health Sciences; 908 p.(2013)
  4. Dreno B, Araviiskaia E, Berardesca E, Bieber T, Hawk J, Sanchez-Viera M, et al. The science of dermocosmetics and its role in dermatology. J EurAcadDermatol Venereol.;28(11):1409-1417. (2014)
  5. Rodrigo FG, Gomes MM, Silva AM, Lopes P. Dermatologia. 4th ed. Lisboa: FundagaoCalousteGulbenkian; 1426 p. (2010)
  6. Guerrero D. Dermocosmetic management of the red face and rosacea. Ann DermatolVenereol. 138(3):215-218 (2011)
  7. Kefala V., Biskanaki F., Rallis E., The microbiome of human skin: a key factor in managing problems in Aesthetics and Dermatology, EpitheoreseKlinikesFarmakologias kai Farmakokinetikes, Greek Edition, in press. [ISSN 1011-6575] (Accepted for publication Dec 2019).
  8. Fernandes AIP. Cuidadosdermocosmeticos para umapelesaudavel: aconselhamentofarmaceuticonoscasosmaiscomuns. Algarve: UniversidadedoAlgarve; (2012)
  9. Anunciato TP. Nutricosmeticos. Ribeirao Preto: Universidade de Sao Paulo, Faculdade de Ciencias Farmaceuticas; (2011)
  10. Catorze, MG. Hidratagaocutanea. Soc Port DermatolVenereol. 68(2):195-215.(2010)
  11. Addor FASA. Skin barrier in rosacea. Anais Bras Dermatol.;91(1):59-63.(2016)
  12. Farmacias Holon – abordagem para a avaliagao e terapeutica; p.4(2014)
  13. Farmacias Holon – protocolo de apoio a dispensa de MSRM;. p.4 (2015)
  14. Bustinduy MC, Fumero VG. Rosacea. Im Piel.;31(2):96-105.(2016)
  15. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am AcadDermatol.69(6):15-26 (2013)
  16. Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, et al. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am AcadDermatol.50(6):907-912. (2004)
  17. Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am AcadDermatol.71(5):973-980.(2014)
  18. Margalit A, Kowalczyk MJ, ZAba R, Kavanagh K. The role of altered cutaneous immune responses in the induction and persistence of rosacea. J DermatolSci.82(1):3-8.(2016)
  19. BanasikowskaA,Singh S. Rosacea. Available from: http://emedicine.medscape.com/ artide/1071429-overview.(2016)
  20. Adams H,CovenC,Grippe K. An overview of rosacea and its challenges. Physic Assist Clin. Volume 1, Issue 2, April, Pages 255-264. (2016)
  21. Pelle MT. Rosacea. In: Goldsmith, LA; Stephen IK, Gilchrest BA, Paller AS, Leffell DJ, Wollf K. Fitzpatrick’s dermatology in general medicine. United States of America: McGraw-Hill Education/Medical. p. 918-919.(2012)
  22. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part II. Topical and systemic therapies in the treatment of rosacea. J Am AcadDermatol.72(5):761-770. (2015)
  23. Amsler E. Rosacea and not always. In: Journees De Dermatologique De Paris, Satellite Symposium Uriage. Immunology at the core of rosacea. p. 3 (2014)
  24. Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. 92(5):234-240. (2013)
  25. Barco D, Alomar A. Rosacea. ActasDermosifiliogr.99(4):244-256 (2008)
  26. Chauhan N, Ellis DAF. Rosacea. PathophysiolManagPrinc Facial Plastic SurgClin North Am.21(1):127-136.(2013)
  27. Wolff K, Johnson R, Saavedra A. Dermatologia de Fitzpatrick – atlas e texto. 7th ed. Porto Alegre:AMGH;1152 p.(2015)
  28. Elewski Be, Draelos Z, Dreno B, Jansen T, Layton A, Picardo M. Rosacea: global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J EurAcadDermatolVenereol.25(2):188-200.(2011)
  29. Oliveros AM. R0sacea, cuperosis y aranasvasculares. SEFAC. 2012;29-37 Pelle MT, Crawford GH,James WD. Rosacea: IItherapy. J Am AcadDermatol.51(4):499-512;513-4. (2004)
  30. Joachim KreskenaUrsulaKindl WalterWigger-Alberti  ,Benjamin M. Clanner-Engelshofen  Markus ReinholDermocosmetics for Use in Rosacea: Guideline of the Society for Dermopharmacy Skin Pharmacol. 31:147–154 (2018)
  31. Levin J, Miller R. A guide to the ingredients and potential benefits of over-the-counter cleansers and moisturizers for rosacea patients. J ClinAesthetDermatol.4(8):31-49. (2011)
  32. Mukhopadhyay P. Cleansers and their role in various dermatological disorders. Indian J Dermatol. 56(1):2-6. (2011)
  33. Draelos ZD. Facial skin care products and cosmetics. ClinDermatol.32(6):809-812.(2014)
  34. Pinheiro LA, Pinheiro AE. A pele da crianga. A cosmeticainfantil sera um mito?ActaPediat Port.38(5):200-8.(2007)
  35. Deshayes P. Rosacea – Dermocosmetic management: Skin- care and corrective make-up [Rosacea – priseen charge des patients: hygiene et maquillage]. AnnalDermatolVenereol. 141(2):179-183. (2014)
  36. Kefala V., Biskanaki F., Rallis E., The Role of Corrective Make up in Dermoaesthetics and cutaneous disorders, Epitheorese Klinikes Farmakologias kai Farmakokinetikes. Greek Edition, (Accepted for publication 2019)
  37. Parada M, Teixeira S. Maquiagem e camuflagem. RBM;[citad 2016 Jun 10]. p.33-37.Available from: www.moreirajr. com.br/revistas.asp?fase=r003&id_materia=3887. (2008)
  38. Lemmel J. Rojeces y cuperosis. Consejofarmaceutico. 28(7):73-79. (2009)
  39. Kharod-Dholakia, B. Ocular rosacea treatment & management. [citad 2017 Jul 3]. Available from: http://emedicine.medscape. com/article/1197341-treatment. (2017)
  40. Nordqvist C. Rosacea: causes, symptoms and treatments. [citad 2016 Jun 9]. Available from: http://www.medicalnewstoday. com/articles/160281.php. (2016)
  41. Gonçalves, M.M.B.M.M., De Pina, M.E.S.R.T. Dermocosmetic care for rosacea. Brazilian Journal of Pharmaceutical Sciences 53(4),e00182 (2017)
  42. TampaΜ., SarbuΜ.Ι.,Matei C., Mitran C.I., Mitran M.I., Caruntu K., Constantin C., Neagu M.,GeorgescuS.R., Photodynamic therapy: A hot topic in skin oncology, Oncol Lett. 17 (5): 4085-4093. Jan 16 (2019)
  43. Xiang Wen , Yong Li,Michael R Hamblin, Photodynamic therapy in dermatology over non-melanoma cancer: an update, Sep; 19: 140-152. (2017)
  44. Fitzpatrick T., Johnson R, Wolff K, Suurmond D, Clinical Dermatology, McGraw-Hill, Greek edition BC Paschalides, pg. 8-11 (2002)
  45. Antoniou C, Katsambas A, Dermatology – Venereology, Broken Hill Publishers LTD, pp. 453-457 (2015)
  46. Banasikowska A., William DJ, Singh S, Talavera F, Mowad C, Leigh Zaenglein A, Rosacea “https://emedicine.medscape.com/article/1071429-overview“, (2018)
  47. Maria Manuel Baia de MeloMaghalges Gonzales , Tavares M., Dermatological care for rosacea acne: Review, Brazilian Journal of Pharmaceutical Sciences53 no.4 Sao Paulo 2017 Epub Mar 05, (2018)
  48. Draelos ZD, Cosmeceuticals for rosacea,Clinics in Dermatology. 35, 213–217, (2017)
  49. Feaster, B., Cline, A., Feldman, S.R., Taylor, S.Clinical effectiveness of novel rosacea therapies,Current Opinion in Pharmacology 46, pp. 14-18  (2019)
  50. Desinioti K., Ktasabas A., Antoniou Ch., The photodynamic therapy for acne treatment,

El. Epit.DermAfrod. pp.96-104 (2014)

  1. Fan, L., Yin, R., Lan, T., Hamblin, M.R. Photodynamic therapy for rosacea in Chinese patients.,Photodiagnosis and Photodynamic Therapy, 24, pp. 82-87. (2018)
  2. Sorbellini, E., Rucco, M., Rinaldi, F. Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update, Lasers in Medical Science, 33 (7), pp. 1431-1439.(2018)
  3. Sun Y.,Chen L.,Zhang Y.,Gao X.,Wu,Y.,Chen H., Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with Rosacea, of Cosm. and Las. Ther. (2018)
  4. Κappas A., Sassa S., Galbraith RA, Nordamann Y. The porphyrias, in Scriver CR, Beaudet AL, Sly WS, Valle D,eds. The metabolisc basis of inherited disease. McGraw-Hill,New York, 6thedn, pp 1305-66, (1989)
  5. Iinuma S, Farshi SS, Ortel B., Hasan T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer, 14:275-92, (1992)
  6. Friedmann, D.P., Goldman, M.P., Fabi, S.G., Guiha, I. Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea, Journal of Cosmetic Dermatology, 15 (4), pp. 407-412. (2016)
Σχετικές Εργασίες – Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
• Chemical Abstracts

• Elsevier’s Bibliographic Databases: Scopus, EMBASE EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Συντακτικη Επιτροπή-Editorial Board

Ετικέτες , , , , , , , , , , , , , , , , , .Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.